Eltrombopag Tablet, Film Coated
Product Images NDC 31722-841

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Eltrombopag (NDC 31722-841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eltrombopag125mgcontainer (Eltrombopag125mgcontainer)

Eltrombopag125mgcontainer (Eltrombopag125mgcontainer)
The text provides information on eltrombopag olamine tablets containing 125 mg of eltrombopag (free acid). It includes instructions for storage at 20° to 25°C, the requirement for safety closures during dispensing, and advises against breaking or chewing the tablets. The medication guide is available and manufactured for Camber Pharmaceuticals, Inc. Additionally, it mentions keeping the tablets and all medicines out of the reach of children. Contact information for the U.S. office is provided.*
FDA Label Image

Eltrombopag25mgcontainer (Eltrombopag25mgcontainer)

Eltrombopag25mgcontainer (Eltrombopag25mgcontainer)
Each film-coated tablet contains eltrombopag olamine equivalent to 25 mg of eltrombopag (free acid). The usual dosage is mentioned in the package insert. Tablets should be stored at 20° to 25°C (68° to 77°F). It is important to use safety closures when dispensing this product unless otherwise directed by physicians. The medication guide is available online at camberpharma.com/medication-guides. The tablets should be swallowed whole and kept out of the reach of children. This medication is manufactured for Camber Pharmaceuticals, Inc. by Annora Pharma Pvt. Ltd.*
FDA Label Image

Eltrombopag50mgcontainer (Eltrombopag50mgcontainer)

Eltrombopag50mgcontainer (Eltrombopag50mgcontainer)
This text provides information about a medication called Eltrombopag in tablet form, with each tablet containing 50 mg of the active ingredient. It includes instructions to dispense the Medication Guide to each patient, swallow tablets whole without splitting or chewing them, and store the medication at a specific temperature range. Safety precautions such as using safety closures and checking for a broken seal under the cap are emphasized. The text also mentions the manufacturer, Camber Pharmaceuticals, Inc., and provides a contact number for further inquiries. It is important to keep the medication and all medicines out of the reach of children.*
FDA Label Image

Eltrombopag75mgcontainer (Eltrombopag75mgcontainer)

Eltrombopag75mgcontainer (Eltrombopag75mgcontainer)
These are instructions for Eltrombopag tablets, each containing 75 mg of eltrombopag olamine. The tablets should be swallowed whole and not split, chewed, or crushed. The usual dosage can be found in the package insert. It should be stored at 20° to 25°C and dispensed in the original bottle with safety closures. It is important not to use if the safety seal is broken or missing. Keep the tablets and all medicines out of the reach of children. The medication guide can be found online, and there is a contact number for further assistance. These tablets are manufactured for Camber Pharmaceuticals, Inc. by Annora Pharma Pvt. Ltd.*
FDA Label Image
FDA Label Image

Eltrombopagstructure (Eltrombopagstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.